Plattform Life Sciences Interview with Dr Michael Thormann, CEO, Origenis Together with the investor Kleiner Perkins, Origenis GmbH...

The industry expert will play a key role in supporting the company’s strategic development. July 23, 2023 Origenis is a technology...

Origenis successfully establishes its new business model for the clinical development of its neuroprotective drug pipeline Martinsried ...